Literature DB >> 33043786

Exploring a role for fatty acid synthase in prostate cancer cell migration.

Mario De Piano1, Valeria Manuelli1, Giorgia Zadra2, Massimo Loda2, Gordon Muir3, Ash Chandra4, Jonathan Morris1, Mieke Van Hemelrijck1, Claire M Wells1.   

Abstract

Fatty acid synthase (FASN) is commonly overexpressed in prostate cancer and associated with tumour progression. FASN is responsible for de novo synthesis of the fatty acid palmitate; the building block for protein palmitoylation. A functional role for FASN in regulating cell proliferation is widely accepted. We recently reported that FASN activity can also mediate prostate cancer HGF-mediated cell motility. Moreover, we found that modulation of FASN expression specifically impacts on the palmitoylation of RhoU. Findings we will describe here. We now report that loss of FASN expression also impairs HGF-mediated cell dissociation responses. Taken together our results provide compelling evidence that FASN activity directly promotes cell migration and supports FASN as a potential therapeutic target in metastatic prostate cancer.

Entities:  

Keywords:  Fatty acid synthase; RhoU; prostate cancer

Mesh:

Substances:

Year:  2020        PMID: 33043786      PMCID: PMC8205051          DOI: 10.1080/21541248.2020.1826781

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  24 in total

1.  Cdc42 is not essential for filopodium formation, directed migration, cell polarization, and mitosis in fibroblastoid cells.

Authors:  Aleksandra Czuchra; Xunwei Wu; Hannelore Meyer; Jolanda van Hengel; Timm Schroeder; Robert Geffers; Klemens Rottner; Cord Brakebusch
Journal:  Mol Biol Cell       Date:  2005-07-12       Impact factor: 4.138

2.  Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.

Authors:  Tao Fang Wang; Heng Wang; Ai Fen Peng; Qing Feng Luo; Zhi Li Liu; Rong Ping Zhou; Song Gao; Yang Zhou; Wen Zhao Chen
Journal:  Biochem Biophys Res Commun       Date:  2013-09-13       Impact factor: 3.575

3.  Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens.

Authors:  R K Bright; C D Vocke; M R Emmert-Buck; P H Duray; D Solomon; P Fetsch; J S Rhim; W M Linehan; S L Topalian
Journal:  Cancer Res       Date:  1997-03-01       Impact factor: 12.701

4.  Dual lipidation of the brain-specific Cdc42 isoform regulates its functional properties.

Authors:  Alexander Wirth; Chen Chen-Wacker; Yao-Wen Wu; Nataliya Gorinski; Mikhail A Filippov; Ghanshyam Pandey; Evgeni Ponimaskin
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

Review 5.  Fatty acid synthase as a potential therapeutic target in cancer.

Authors:  Richard Flavin; Stephane Peluso; Paul L Nguyen; Massimo Loda
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

6.  PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity.

Authors:  A D Whale; A Dart; M Holt; G E Jones; C M Wells
Journal:  Oncogene       Date:  2012-06-11       Impact factor: 9.867

7.  Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges.

Authors:  Subhamoy Dasgupta; Srinivasa Srinidhi; Jamboor K Vishwanatha
Journal:  J Carcinog       Date:  2012-02-17

8.  PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration.

Authors:  Helen King; Kiruthikah Thillai; Andrew Whale; Prabhu Arumugam; Hesham Eldaly; Hemant M Kocher; Claire M Wells
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

Review 9.  Regulation and functions of RhoU and RhoV.

Authors:  Richard G Hodge; Anne J Ridley
Journal:  Small GTPases       Date:  2017-11-30

10.  PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion.

Authors:  Anna E Dart; Gary M Box; William Court; Madeline E Gale; John P Brown; Sarah E Pinder; Suzanne A Eccles; Claire M Wells
Journal:  J Cell Biol       Date:  2015-11-23       Impact factor: 10.539

View more
  3 in total

Review 1.  Post-Translational Modifications That Drive Prostate Cancer Progression.

Authors:  Ivana Samaržija
Journal:  Biomolecules       Date:  2021-02-09

2.  Nischarin Deletion Reduces Oxidative Metabolism and Overall ATP: A Study Using a Novel NISCHΔ5-6 Knockout Mouse Model.

Authors:  Tina H Nguyen; Hassan Yousefi; Samuel C Okpechi; Lothar Lauterboeck; Shengli Dong; Qinglin Yang; Suresh K Alahari
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 6.208

Review 3.  The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer.

Authors:  Eleazer P Resurreccion; Ka-Wing Fong
Journal:  Metabolites       Date:  2022-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.